000 01331 a2200361 4500
005 20250516130533.0
264 0 _c20130617
008 201306s 0 0 eng d
022 _a1399-6576
024 7 _a10.1111/aas.12010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFlaatten, H
245 0 0 _aThe Scandinavian Critical Care Trials Group: producing important new findings in challenging times.
_h[electronic resource]
260 _bActa anaesthesiologica Scandinavica
_cFeb 2013
300 _a138-40 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aClinical Trials as Topic
650 0 4 _aCritical Care
_xtrends
650 0 4 _aDrug Industry
_xlegislation & jurisprudence
650 0 4 _aGlutamine
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHydroxyethyl Starch Derivatives
_xadverse effects
650 0 4 _aIsotonic Solutions
_xadverse effects
650 0 4 _aPlasma Substitutes
_xadverse effects
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aResuscitation
650 0 4 _aRinger's Solution
650 0 4 _aScandinavian and Nordic Countries
700 1 _aHaney, M
700 1 _aWernerman, J
773 0 _tActa anaesthesiologica Scandinavica
_gvol. 57
_gno. 2
_gp. 138-40
856 4 0 _uhttps://doi.org/10.1111/aas.12010
_zAvailable from publisher's website
999 _c22397474
_d22397474